Skip to content

13F-HR filed by Yu Fan

Yu Fan filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 5 holding rows worth $1,274,878.

Accession
0000950123-23-008115
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A combination report, 5 entries on the cover page, a total value of $1,274,878 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,274,878 with VALUE read as dollars as filed, 13F file number 028-20833. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerABG Innovation Capital Partners III GP Limited 028-20837
  • reports for this filerAlly Bridge Group (NY) LLC 028-20834

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SONENDO INC835431107Common Stocks547,945$745,205dollars as filed
CASTLE BIOSCIENCES INC14843C105COMMON STOCK20,592$282,522dollars as filed
Pyxis Oncology, Inc (formerly Apexigen)03759B102COM401,757$172,675dollars as filed
AEGLEA BIOTHERAPEUTICS INC00773J103COM112,044$50,476dollars as filed
PRENETICS GLOBAL LTD SHS NEWG72245106Stock25,000$24,000dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-23-008115this filing2023-08-14acceptance time not in the bulk data set